PROVIRON

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

Mesterolone

제공처:

Bayer Australia Ltd

수업:

Medicine Registered

환자 정보 전단

PROVIRON
® 
CMI 

  1 
PROVIRON
®

(PRO·VAI·RON) 
_mesterolone _

CONSUMER MEDICINE INFORMATION 

WHAT IS IN THIS 
LEAFLET 
This leaflet answers some common 
questions about Proviron. 
It does not contain all of the 
available information.  

It does not take the place of talking 
to your doctor or pharmacist. 

All medicines have risks and 
benefits. Your doctor has weighed 
the risks of you taking Proviron 
against the benefits they expect it 
will have for you. 

IF YOU HAVE ANY CONCERNS ABOUT 
TAKING THIS MEDICINE, ASK YOUR 
DOCTOR OR PHARMACIST. 

KEEP THIS LEAFLET WITH THE 
MEDICINE. 
You may need to read it again. 
WHAT PROVIRON IS 
USED FOR 
Proviron is used to replace 
testosterone in men with 
hypogonadism. Male hypogonadism 
is a condition when the body does 
not produce enough testosterone. 

Testosterone is a natural male 
hormone, known as an androgen, 
which controls normal sexual 
development in men. 

Testosterone is essential for the 
development and maintenance of 
the male reproductive organs as 
well as other male characteristics, 
such as hair growth, deep voice, 
sexual drive, muscle mass and body 
fat distribution. 

Proviron is for use in male patients 
only. 

ASK YOUR DOCTOR IF YOU HAVE ANY 
QUESTIONS ABOUT WHY THIS MEDICINE 
HAS BEEN PRESCRIBED FOR YOU. 
Your doctor may have prescribed it 
for another reason. 
BEFORE YOU USE 
PROVIRON 
_WHEN YOU MUST NOT TAKE IT _
DO NOT TAKE PROVIRON IF YOU HAVE 
AN ALLERGY TO: 
• mesterolone, the active ingredient 
in Proviron 
• any of the ingredients listed at the 
end of this leaflet. 

Some of the symptoms of an 
allergic reaction may include: 
• shortness of breath 
• wheezing or difficulty breathing 
• swelling of the face, lips, tongue 
or other parts of the body 
• rash, itching or hives on the skin. 

DO NOT TAKE PROVIRON IF YOU HAVE: 
  prostate cancer 
  previous or existing liver 
tumours 
�